Predicting and Responding to Emerging Viral Infections
Oct 13–16, 2025 | Crowne Plaza Geneva, Geneva, Switzerland
Scientific Organizers:
Suresh Mahalingam, Christopher F. Basler, Felicity Burt and Alina Baum
In Person
On Demand
Oct 13–16, 2025 | Crowne Plaza Geneva, Geneva, Switzerland
Scientific Organizers:
Suresh Mahalingam, Christopher F. Basler, Felicity Burt and Alina Baum
Available Formats:
In Person
On Demand
Supported by the Directors' Fund
Available Formats: = In Person = On Demand
Booking Function
Monday, October 13, 2025
Merchandise Options
Registration Options
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Tuesday, October 14, 2025
Breakfast
7:30–8:30 AM
Poster Setup
8:00–8:30 AM
Poster Viewing
8:00–5:00 PM
Welcome and Keynote Address
8:30–9:30 AM
Jeremy Farrar †, World Health Organization
Talk Title to be Announced
Talk Title to be Announced
Predictive Modeling and Surveillance
9:30–11:45 AM
Bethan Purse, UK Centre for Ecology & Hydrology
Environmental Change and Drivers of Emergence of Vector-Borne Viruses
Environmental Change and Drivers of Emergence of Vector-Borne Viruses
Speaker to be Announced
Houriiyah Tegally, Stellenbosch University
The Role of Data Streams in Understanding Infection Dynamics
The Role of Data Streams in Understanding Infection Dynamics
Felicity Burt, University of The Free State
Diagnosis and Surveillance of Emerging Arboviruses in Africa
Diagnosis and Surveillance of Emerging Arboviruses in Africa
Short Talk(s) Chosen from Abstracts
Coffee Break
10:00–10:20 AM
Lunch
11:45–12:45 PM
Posters
12:00–2:30 PM
Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Coffee Available
4:30–5:00 PM
Pandemic Preparedness and Response Strategies
5:00–7:00 PM
Rick Arthur Bright, Bright Global Health
Detecting and Responding to Emerging Viral Infections
Detecting and Responding to Emerging Viral Infections
Pei-Yong Shi †, GSK
GSK's Role in Strengthening Pandemic Preparedness
GSK's Role in Strengthening Pandemic Preparedness
Anish Thekkumkara Surendran, Kerala One Health Centre for Nipah Research
Nipah Virus - Smart Policy Changes that can Help Quell Pandemic Risk
Nipah Virus - Smart Policy Changes that can Help Quell Pandemic Risk
Short Talk(s) Chosen from Abstracts
On Own for Dinner
7:00–8:00 PM
Wednesday, October 15, 2025
Breakfast
7:30–8:30 AM
Poster Setup
8:00–8:30 AM
Poster Viewing
8:00–5:00 PM
Zoonoses 1 - One Health
8:30–11:30 AM
Martin Groschup †, Friedrich-Loeffler-Institut
Arbovirus and Zoonotic Virus Surveillance in Africa: Emphasizing a One Health Approach
Arbovirus and Zoonotic Virus Surveillance in Africa: Emphasizing a One Health Approach
Ian Brown, The Pirbright Institute
One Health Approach to Avian and Swine Influenza
One Health Approach to Avian and Swine Influenza
Speaker to be Announced
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Lunch
11:30–12:30 PM
Posters
12:00–2:30 PM
Career Roundtable
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Zoonoses 2 – Virus-Host Interactions
5:00–7:00 PM
Richard J. Webby, St. Jude Children's Research Hospital
Talk Title to be Announced
Talk Title to be Announced
Speaker to be Announced
Christopher F. Basler, Icahn School of Medicine, Mt Sinai
Virus-Host Interactions of Filoviruses with a Focus on Ebola and Marburg
Virus-Host Interactions of Filoviruses with a Focus on Ebola and Marburg
Short Talk(s) Chosen from Abstracts
On Own for Dinner
7:00–8:00 PM
Thursday, October 16, 2025
Breakfast
7:30–8:30 AM
Vaccines
8:30–11:30 AM
Martina Schneider †, Valneva SE
IXCHIQ®, the First FDA-Approved Chikungunya Vaccine
IXCHIQ®, the First FDA-Approved Chikungunya Vaccine
Andrea Marzi, NIAID, National Institutes of Health
Current Filovirus Vaccine Candidates – Focus on VSV-based Vaccines
Current Filovirus Vaccine Candidates – Focus on VSV-based Vaccines
George Warimwe, University of Oxford
Combating Rift Valley Fever - ChAdOx1 Rift Valley Fever Vaccine Safety and Immunogenicity: Phase 1 Trial in Adults
Combating Rift Valley Fever - ChAdOx1 Rift Valley Fever Vaccine Safety and Immunogenicity: Phase 1 Trial in Adults
Kizzmekia S. Corbett-Helaire, Harvard T.H. Chan School of Public Health
Preparing for a Pandemic: Lessons from COVID Vaccines and Applications to Other Viral Diseases
Preparing for a Pandemic: Lessons from COVID Vaccines and Applications to Other Viral Diseases
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Lunch
11:30–12:30 PM
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Coffee Available
4:30–5:00 PM
Therapeutics
5:00–6:45 PM
Laura M Walker, Moderna
Advancing Infectious Disease Treatment: The Role of mRNA Therapeutics
Advancing Infectious Disease Treatment: The Role of mRNA Therapeutics
Suresh Mahalingam, Griffith University
Advancements in Drug Repurposing and New Therapeutics for Arthritogenic Alphaviruses: Tackling Acute and Chronic Disease
Advancements in Drug Repurposing and New Therapeutics for Arthritogenic Alphaviruses: Tackling Acute and Chronic Disease
Alina Baum, Regeneron Pharmaceuticals
Filovirus Therapeutic Antibodies
Filovirus Therapeutic Antibodies
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions
6:45–7:00 PM
On Own for Dinner
7:00–8:00 PM
Friday, October 17, 2025
Departure
12:00–11:59 PM
Subscribe for Updates